Ander Vergara

846 total citations
22 papers, 519 citations indexed

About

Ander Vergara is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Nephrology. According to data from OpenAlex, Ander Vergara has authored 22 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Surgery and 8 papers in Nephrology. Recurrent topics in Ander Vergara's work include Diabetes Treatment and Management (10 papers), Chronic Kidney Disease and Diabetes (7 papers) and Pancreatic function and diabetes (6 papers). Ander Vergara is often cited by papers focused on Diabetes Treatment and Management (10 papers), Chronic Kidney Disease and Diabetes (7 papers) and Pancreatic function and diabetes (6 papers). Ander Vergara collaborates with scholars based in Spain, Canada and Germany. Ander Vergara's co-authors include María José Soler, Conxita Jacobs-Cachá, Clara García-Carro, Daniel Serón, Sheila Bermejo, María Azancot, Nuria Garcı́a-Fernández, Josune Orbe, Jacobo Sellarés and Gavin Y. Oudit and has published in prestigious journals such as International Journal of Molecular Sciences, Nephrology Dialysis Transplantation and Frontiers in Pharmacology.

In The Last Decade

Ander Vergara

22 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ander Vergara Spain 13 174 157 115 111 96 22 519
Conxita Jacobs-Cachá Spain 13 177 1.0× 234 1.5× 92 0.8× 136 1.2× 74 0.8× 23 575
Sho Kinguchi Japan 15 146 0.8× 132 0.8× 88 0.8× 113 1.0× 155 1.6× 51 538
Yi‐Chih Lin Taiwan 7 140 0.8× 165 1.1× 77 0.7× 119 1.1× 60 0.6× 16 483
Takahiro Yamaji Japan 13 131 0.8× 139 0.9× 74 0.6× 107 1.0× 81 0.8× 28 520
Hyun Wha Chung South Korea 9 214 1.2× 139 0.9× 128 1.1× 227 2.0× 78 0.8× 13 574
Carla Ferri Spain 14 134 0.8× 322 2.1× 110 1.0× 166 1.5× 68 0.7× 33 691
Norihisa Osawa Japan 10 212 1.2× 106 0.7× 122 1.1× 128 1.2× 45 0.5× 14 495
Maria G. Dekker Canada 9 201 1.2× 239 1.5× 65 0.6× 70 0.6× 134 1.4× 9 474
Ryu Kobayashi Japan 15 162 0.9× 93 0.6× 81 0.7× 125 1.1× 227 2.4× 42 521
Kumiko Moriwaki Japan 14 133 0.8× 126 0.8× 113 1.0× 103 0.9× 122 1.3× 24 470

Countries citing papers authored by Ander Vergara

Since Specialization
Citations

This map shows the geographic impact of Ander Vergara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ander Vergara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ander Vergara more than expected).

Fields of papers citing papers by Ander Vergara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ander Vergara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ander Vergara. The network helps show where Ander Vergara may publish in the future.

Co-authorship network of co-authors of Ander Vergara

This figure shows the co-authorship network connecting the top 25 collaborators of Ander Vergara. A scholar is included among the top collaborators of Ander Vergara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ander Vergara. Ander Vergara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vergara, Ander, Francisco Gonçalves, Sheila Bermejo, et al.. (2024). SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice. Frontiers in Pharmacology. 15. 1415879–1415879. 6 indexed citations
2.
Sun, Qiuyu, Cory S. Wagg, Amanda Almeida de Oliveira, et al.. (2023). Stimulating cardiac glucose oxidation lessens the severity of heart failure in aged female mice. Basic Research in Cardiology. 119(1). 133–150. 8 indexed citations
3.
Alvarez, E., et al.. (2023). Endothelin Receptor Antagonists in Kidney Disease. International Journal of Molecular Sciences. 24(4). 3427–3427. 32 indexed citations
4.
Agraz, Irene, Ander Vergara, Natàlia Ramos, et al.. (2022). COVID-19 infection and renal injury: where is the place for acute interstitial nephritis disease?. Clinical Kidney Journal. 15(9). 1698–1704. 7 indexed citations
5.
Vergara, Ander, et al.. (2022). Antioxidant Roles of SGLT2 Inhibitors in the Kidney. Biomolecules. 12(1). 143–143. 35 indexed citations
6.
Vergara, Ander, Frank Stein, Mandy Rettel, et al.. (2022). The membrane-associated protein 17 (MAP17) is up-regulated in response to empagliflozin on top of RAS blockade in experimental diabetic nephropathy. Clinical Science. 137(1). 87–104. 6 indexed citations
7.
Jacobs-Cachá, Conxita, Ander Vergara, Jacobo Sellarés, et al.. (2021). A Specific Tubular ApoA-I Distribution Is Associated to FSGS Recurrence after Kidney Transplantation. Journal of Clinical Medicine. 10(10). 2174–2174. 2 indexed citations
8.
Vergara, Ander, Néstor Toapanta, Andrés Villegas, et al.. (2021). The Impact of Age on Mortality in Chronic Haemodialysis Population with COVID-19. Journal of Clinical Medicine. 10(14). 3022–3022. 7 indexed citations
9.
Jacobs-Cachá, Conxita, et al.. (2021). El rol del sistema renina angiotensina a nivel cerebral. Hipertensión y Riesgo Vascular. 38(3). 125–132. 10 indexed citations
10.
García-Carro, Clara, Irene Agraz, Néstor Toapanta, et al.. (2021). COVID-19 in CKD Patients: Lessons from 553 CKD Patients with Biopsy-Proven Kidney Disease. Kidney & Blood Pressure Research. 46(4). 452–459. 1 indexed citations
11.
Vergara, Ander, Conxita Jacobs-Cachá, Begoña Benito, et al.. (2021). Effect of ramipril on kidney, lung and heart ACE2 in a diabetic mice model. Molecular and Cellular Endocrinology. 529. 111263–111263. 6 indexed citations
12.
Oliveira, Amanda Almeida de, et al.. (2021). Apelin pathway in cardiovascular, kidney, and metabolic diseases: Therapeutic role of apelin analogs and apelin receptor agonists. Peptides. 147. 170697–170697. 34 indexed citations
13.
García-Carro, Clara, Ander Vergara, Sheila Bermejo, et al.. (2021). A Nephrologist Perspective on Obesity: From Kidney Injury to Clinical Management. Frontiers in Medicine. 8. 655871–655871. 62 indexed citations
14.
García-Carro, Clara, Ander Vergara, Sheila Bermejo, et al.. (2021). How to Assess Diabetic Kidney Disease Progression? From Albuminuria to GFR. Journal of Clinical Medicine. 10(11). 2505–2505. 23 indexed citations
15.
Vergara, Ander, et al.. (2020). Revisiting Experimental Models of Diabetic Nephropathy. International Journal of Molecular Sciences. 21(10). 3587–3587. 72 indexed citations
16.
Jacobs-Cachá, Conxita, Ander Vergara, Clara García-Carro, et al.. (2020). Challenges in primary focal segmental glomerulosclerosis diagnosis: from the diagnostic algorithm to novel biomarkers. Clinical Kidney Journal. 14(2). 482–491. 18 indexed citations
17.
Garcı́a-Fernández, Nuria, et al.. (2020). Matrix Metalloproteinases in Diabetic Kidney Disease. Journal of Clinical Medicine. 9(2). 472–472. 78 indexed citations
18.
García-Carro, Clara, Ander Vergara, Irene Agraz, et al.. (2019). The New Era for Reno-Cardiovascular Treatment in Type 2 Diabetes. Journal of Clinical Medicine. 8(6). 864–864. 18 indexed citations
19.
Vergara, Ander, Conxita Jacobs-Cachá, & María José Soler. (2019). Sodium-glucose cotransporter inhibitors: beyond glycaemic control. Clinical Kidney Journal. 12(3). 322–325. 27 indexed citations
20.
Górriz, José Luis, Juan F. Navarro‐González, Alberto Ortíz, et al.. (2019). Sodium-glucose cotransporter 2 inhibition: towards an indication to treat diabetic kidney disease. Nephrology Dialysis Transplantation. 35(Supplement_1). i13–i23. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Conxita Jacobs-Cachá Breakdown of academic impact, for papers by Sho Kinguchi Breakdown of academic impact, for papers by Yi‐Chih Lin Breakdown of academic impact, for papers by Takahiro Yamaji Breakdown of academic impact, for papers by Hyun Wha Chung Breakdown of academic impact, for papers by Carla Ferri Breakdown of academic impact, for papers by Norihisa Osawa Breakdown of academic impact, for papers by Maria G. Dekker Breakdown of academic impact, for papers by Ryu Kobayashi Breakdown of academic impact, for papers by Kumiko Moriwaki
Rankless by CCL
2026